R&D and marketing integration in NPD in the pharmaceutical industry

Mohammed Rafiq (Mohammed Rafiq is a Senior Lecturer in Retailing and Marketing at Loughborough University, Loughborough, UK.)
Tim Saxon (Tim Saxon is Senior Director, International Business Development, at Whitehall Robins, Madison, New Jersey, USA.)

European Journal of Innovation Management

ISSN: 1460-1060

Publication date: 1 December 2000


Reports exploratory research focusing on this neglected area based on semi‐structured interviews with R&D and marketing managers of major international pharmaceutical companies. Major findings include the fact that few of the responding companies integrate marketing and R&D in the formulation of product development strategy which is a considerable source of resentment between the marketing and R&D functions. Also, whilst the move from functional specialisation to cross‐functional therapeutic teams is effective in focusing NPD activity and delivering projects on time, they ignore innovative opportunities that are not directly related to the project. External specialist companies are an increasingly important source of innovation and the ability to manage them effectively is essential for maintaining competitive advantage in the pharmaceutical industry.



Rafiq, M. and Saxon, T. (2000), "R&D and marketing integration in NPD in the pharmaceutical industry", European Journal of Innovation Management, Vol. 3 No. 4, pp. 222-231. https://doi.org/10.1108/14601060010352506

Download as .RIS




Copyright © 2000, MCB UP Limited

Please note you might not have access to this content

You may be able to access this content by login via Shibboleth, Open Athens or with your Emerald account.
If you would like to contact us about accessing this content, click the button and fill out the form.
To rent this content from Deepdyve, please click the button.